Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.36 |
| ▸ | GABRP | O00591 | 2/20 | 0.33 |
| ▸ | GABRD | O14764 | 2/20 | 0.33 |
| ▸ | GABRA1 | P14867 | 2/20 | 0.33 |
| ▸ | GABRB1 | P18505 | 2/20 | 0.33 |
| ▸ | GABRG2 | P18507 | 2/20 | 0.33 |
| ▸ | GABRB3 | P28472 | 2/20 | 0.33 |
| ▸ | GABRA5 | P31644 | 2/20 | 0.33 |
| ▸ | GABRA3 | P34903 | 2/20 | 0.33 |
| ▸ | GABRA2 | P47869 | 2/20 | 0.33 |
| ▸ | GABRB2 | P47870 | 2/20 | 0.33 |
| ▸ | GABRA4 | P48169 | 2/20 | 0.33 |
| ▸ | GABRE | P78334 | 2/20 | 0.33 |
| ▸ | GABRA6 | Q16445 | 2/20 | 0.33 |
| ▸ | GABRG1 | Q8N1C3 | 2/20 | 0.33 |
| ▸ | GABRG3 | Q99928 | 2/20 | 0.33 |
| ▸ | GABRQ | Q9UN88 | 2/20 | 0.33 |
| ▸ | GABRR1 | P24046 | 2/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3230815 | 0.82 | HSD17B10 (0.39) | TDP1GABRR1 | |
| SCHEMBL31298925 | 0.82 | TSHR (0.42) | TDP1ALDH1A1 | |
| SCHEMBL3804215 | 0.81 | — | — | |
| SCHEMBL3503148 | 0.79 | GABRP (0.34) | GABRPGABRDGABRA1GABRB1GABRG2 | |
| SCHEMBL730425 | 0.78 | CYP1A2 (0.35) | TDP1GABRPGABRDGABRA1GABRB1 | |
| SCHEMBL8197005 | 0.78 | CA1 (0.45) | — | |
| SCHEMBL30539139 | 0.77 | CA1 (0.53) | — | |
| SCHEMBL17183778 | 0.76 | SLC7A5 (0.41) | TDP1GABRR1ALDH1A1 | |
| SCHEMBL8401516 | 0.76 | — | — | |
| SCHEMBL8402309 | 0.76 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3377549-B1 | PROLIFEROUS POLYMERS COMPRISING LACTAMIC MOIETIES | ISP INVESTMENTS LLC (US) | 2024-09-04 | — | — | EP | disclosed |
| US-10844154-B2 | Proliferous copolymers comprising lactamic moieties | ISP INVESTMENTS LLC (US) | 2020-11-24 | — | — | US | disclosed |
| CN-110325570-A | Method for preparing functional water-soluble film | 巴斯夫欧洲公司 | 2019-10-11 | — | — | CN | disclosed |
| CN-110291120-A | Multilayer film, its production method and purposes | 巴斯夫欧洲公司 | 2019-09-27 | — | — | CN | disclosed |
| US-20180340034-A1 | PROLIFEROUS COPOLYMERS COMPRISING LACTAMIC MOIETIES | ISP INVESTMENTS LLC (US) | 2018-11-29 | — | — | US | disclosed |
| EP-3377549-A1 | PROLIFEROUS POLYMERS COMPRISING LACTAMIC MOIETIES | ISP Investments LLC (US) | 2018-09-26 | — | — | EP | disclosed |
| CN-105518038-A | Solid polymer composition obtained by polymerization of an acid group-containing monomer in the presence of a polyether compound | BASF SE | 2016-04-20 | — | — | CN | disclosed |
| US-9023931-B2 | Oxidation-sensitive, low-peroxide polymer comprising at least one inorganic phosphorus compound | BASF SE (DE) | 2015-05-05 | — | — | US | disclosed |
| US-8623978-B2 | Process for the preparation of low-peroxide crosslinked vinyllactam polymer | BASF SE (DE) | 2014-01-07 | — | — | US | disclosed |
| US-20130108959-A1 | USE OF A COMPOSITION COMPRISING VINYL MONOMER-COMPRISING POLYMER, SOLVENT AND AT LEAST ONE HALOGEN-FREE BIOCIDE | BASF SE (DE) | 2013-05-02 | — | — | US | disclosed |
| CN-101233160-B | copolymer containing siloxane perssad, preparation method thereof and application | BASF AG | 2012-11-28 | — | — | CN | disclosed |
| US-20120261299-A1 | OXIDATION-SENSITIVE, LOW-PEROXIDE POLYMER COMPRISING AT LEAST ONE INORGANIC PHOSPHORUS COMPOUND | BASF SE (DE) | 2012-10-18 | — | — | US | disclosed |
| WO-2012140561-A1 | OXIDATION-SENSITIVE, LOW-PEROXIDE POLYMER COMPRISING AT LEAST ONE INORGANIC PHOSPHORUS COMPOUND | BASF SE (DE) | 2012-10-18 | — | — | WO | disclosed |
| US-20120130028-A1 | PROCESS FOR THE PREPARATION OF LOW-PEROXIDE CROSSLINKED VINYLLACTAM POLYMER | BASF SE (DE) | 2012-05-24 | — | — | US | disclosed |
| CN-101484130-A | Neutralized acid group-containing polymers and the use thereof | BASF AG (DE) | 2009-07-15 | — | — | CN | disclosed |
| CN-101233160-A | Use of anionically and cationically ampholytic copolymers | BASF AG (DE) | 2008-07-30 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10844154-B2 | Proliferous copolymers comprising lactamic moieties | PCNA, MKI67, CCNA1 | TDP1 3053/4885GABRP 1915/4885GABRD 1713/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.